Bharat Biotech approaches WHO for emergency use listing for Covaxin: Sources
Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday.
READ MORE:
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
